An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This is a phase III randomized study comparing induction treatments of Gemcitabine and
Carboplatin versus Paclitaxel and Carboplatin, with or without consolidation therapy for
patients that do not have any evidence of disease after completion of six cycles of induction
therapy. Patients with disease after induction therapy will crossover to receive single agent
therapy.